Please do not leave this page until complete. This can take a few moments.
Worcester State University will honor an alumnus who donated $1 million to fund STEM research and education.
There are many blocks needed to build a successful business. These blocks are dynamic and contain specific infrastructures and characteristics, but fit together in a cohesive manner.
Marlborough drugmaker RXi Pharmaceuticals Corp. has completed its purchase of Cambridge cancer treatment company MirImmune Inc.
The National Science Foundation has awarded $1.1 million to a Worcester Polytechnic Institute professor for a five-year study of bacteria in stressful conditions, the school announced Wednesday.
The Massachusetts Life Sciences Center on Thursday announced it is now accepting applications for a new round of its Tax Incentive Program and is encouraging companies outside of Greater Boston to apply.
Researchers at Worcester Polytechnic Institute (WPI) have developed a chip that could lead to early detection of cancer metastasis.
Harvard Pilgrim Health Care Institute researchers have received $3.2 million in funding to study how high-deductible health plans and preventative drug lists impact asthma patients.
Americans view healthcare professionals as more trustworthy than most other professionals, according to annual Gallup survey results released Monday.
UMass Medical School is now home to two high-resolution microscopes, the first of their kind in New England.
As the Acton company moves forward with new leadership trying to rectify its financials, SeaChange International on Tuesday announced it is nearing a deal with a London-based film and television distributor to use SeaChange's platform to stream
Marlborough drugmaker Sunovion Pharmaceuticals has agreed to acquire Toronto-based Cynapsus Therapeutics for $624 million sometime in the fourth quarter.
Worcester Polytechnic Institute has named Bogdan Vernescu as the school's vice provost for research, putting him in charge of directing the school's research and controlling its intellectual property and innovation.
Bloomberg Business has named Massachusetts as the most innovative state in America, just beating out Silicon Valley and California in the rankings.
Worcester pharmaceutical firm AbbVie has received priority review status from the U.S. Food & Drug Administration for its drug meant to treat those suffering from chronic hepatitis C virus.
Marlborough-based Ocata Therapeutics is moving forward on research that could lead to a steady supply of tissue to treat diseased and injured corneas.
Jean-Pierre Garnier has been appointed chairman of the board of Alzheon Inc., a Framingham-based private biopharmaceutical startup focused on developing treatments for Alzheimer’s disease.